In situ injection of hUCMSCs can restore ovarian function and fertility in POF mice by reducing granulosa cell apoptosis and upregulating steroidogenesis pathways.
Abstract
Background
Premature Ovarian Failure (POF) is a dysfunction that severely impacts women's physiological health and reproductive function. Human umbilical cord mesenchymal stem cell (hUCMSC) transplantation offers a promising therapeutic option for restoring ovarian function. However, its efficacy and underlying mechanisms are not yet fully understood.
Methods
A POF mouse model was established using cyclophosphamide induction, and hUCMSCs were transplanted into the ovaries through in situ injection. Treatment efficacy was evaluated by assessing hormone levels, estrous cycle, follicle count, and reproductive outcomes. Furthermore, metabolomic sequencing was performed on the ovarian tissues of mice to explore the mechanism underlying the therapeutic effect of hUCMSCs.
Results
Compared to the POF control group, the hUCMSC treatment group showed significant improvements: primordial and primary follicle counts increased by 8-fold and 5-fold respectively, while atretic follicle ratios decreased by 50%. Pregnancy rates in treatment group increased from 25% to 75%, with average litter sizes rising from 1.5 pups/litter to 4.5 pups/litter. The expression of key genes (Cyp11a1, Cyp19a1, Star) in the steroidogenesis pathway was significantly upregulated in ovarian tissues, which restored the levels of steroid hormones such as progesterone and thereby stabilized serum sex hormone levels.
Conclusions
In situ injection of hUCMSCs can restore ovarian function and fertility in POF mice by reducing granulosa cell apoptosis and upregulating steroidogenesis pathways.
BACKGROUND
Premature ovarian insufficiency (POI) is characterized by reduced ovarian reserve and disrupted folliculogenesis, often driven by granulosa cell (GC) dysfunction. Traditional Chinese medicine formula TSZF has been widely used for POI, yet its mechanisms and active components remain unclear. This study aimed...
Si-Qi Li, Yuan Li, Jian-Ying Kang et al.· Tissue & Cell· 0 citations
The regulatory role of PPARγ in linking metabolic signaling to AMH regulation and early follicle dynamics is supported, providing mechanistic insights into age-dependent changes in ovarian function.
Mi Seon Park, Ji Young Hwang, Junghye Kim et al.· Journal of Ovarian Research· 0 citations
Abstract Premature ovarian insufficiency (POI) is a heterogeneous reproductive and endocrine disorder characterized by impaired ovarian function before the age of 40 years. Conventional management, particularly hormone therapy, addresses hypoestrogenic symptoms and long-term health risks but does not reliably restore e...
Shu-Na Zhang, Fei Wang, Rui-Qi Wang et al.· International Journal of Gen...· 0 citations
Preliminary findings suggest ADSC therapy represents a promising adjunctive regenerative strategy in reproductive medicine, and larger prospective randomized controlled studies are required to establish efficacy, long-term safety, and reproductive outcomes.
Sarah Ibrahim, N. Museridze, Ivane Kutivadze· Medical times· 0 citations
Bone marrow mesenchymal stem cells (BMSCs) are stromal cells that can self-renew. Exosomes (EXOs) perform many biological functions particularly in cell-cell communication. Peripheral blood mononuclear cells (PBMNCs) have the ability to differentiate into numerous mature functional cell types in specific microenvironme...
Yasmine Osama Mohamed Mokhtar, Nada Amgad Mohamed Abdel Majeed, Manar Fouli Gaber Ibrahim et al.· Tissue Barriers· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.